This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 06 Nov 2017  |  South Asia, Middle East & North Africa  |  Market Research

    Growth and Investment Opportunities in Nepal Healthcare Market, 2017

    Incidence of Non-Communicable Diseases increasing leading to demand for specialty services

    This industry docket assess Nepal's healthcare market and highlights investment opportunities therein. The country lacks centers of excellence in tertiary care leading to outflow of patients seeking the same. Nepal is currently seeing increasing investment by private and corporate hospital sectors in speciality services like Cardiac Sciences, Neu...

    $1,500.00
  2. 22 Jun 2017  |  Asia Pacific  |  Market Research

    Malaysia, Singapore, and Indonesia Transformational Health Insights, 2017–2022

    Rapid Growth, Reforms, and Partnerships are Transforming Healthcare Systems in Malaysia, Singapore, and Indonesia

    Southeast Asia (SEA) is emerging as the gold mine for both local and international healthcare vendors. Within SEA, Malaysia, Singapore, and Indonesia still have unexplored and under-served markets providing boundless opportunities for healthcare vendors with innovative products and services. To be able to capitalize on the market, medical device ma...

    $1,500.00
  3. 19 Jun 2017  |  Asia Pacific  |  Mega Trends

    Growth Opportunities in the APAC IVD Market, Forecast to 2021

    Digital Pathology and Laboratory Automation are Two Strategic Themes Driving the Growth of the IVD Market

    The study aims to analyze and forecast the Asia Pacific (APAC) in-vitro diagnostics (IVD) market outlook and technology trends for 2016. Research Scope: • Key trends and opportunities in the IVD market, which has been segmented into 8 major divisions: o Immunochemistry o Self-monitoring Blood Glucose (SMBG) Meter o Hematology o Point-of-care...

    $4,950.00
  4. 20 Apr 2017  |  Asia Pacific  |  Market Research

    The Philippines Transformational Healthcare Insights, 2016

    Current Trends and Challenges Encountered in the Road to Achieving Universal Healthcare Coverage

    The Philippines is a part of the Association of Southeast Asian Nations (ASEAN) community and one of the fastest growing healthcare markets in the region. With regard to healthcare, the Philippine Government has been looking at ways to achieve 100% enrolment to PhilHealth by 2020. One of the means is by mandating all Filipinos to enrol to PhilHealt...

    $1,500.00
  5. 23 Mar 2017  |  Asia Pacific  |  Market Research

    APAC Molecular Diagnostics Market, Forecast to 2021

    Pharmerging Economies with Rising Healthcare Demands will Accentuate Growth

    The molecular diagnostics (MDx) market in APAC is witnessing rapid growth due to two main factors: the high adoption of MDx tests for infectious diseases applications in emerging countries, and the advent of innovative diagnostic solutions in cancer and NGS based solutions that are gaining pace in Asia. Multinational companies have not only identif...

    $4,950.00
  6. 24 Jan 2017  |  Asia Pacific  |  Market Research

    Game-changing Strategies of APAC Pharma Companies

    Growing Focus on Specific Therapy Areas and Shift Towards Value-based Delivery Model Expected to Boost Pharma Market

    Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing Asia-Pacific (APAC) pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing...

    $1,500.00
  7. 15 Dec 2015  |  Asia Pacific  |  Market Research

    Analysis of the Medical Imaging Market in Selected ASEAN Countries

    Growth and Trends in CT, MR, PET, and SPECT Modalities

    This research service provides an analysis of the medical imaging market in Indonesia, Malaysia, Singapore, and Thailand. It provides a detailed analysis of current trends, market size, revenue forecasts, and drivers and restraints for the computed tomography (CT), medical resonance (MR), Positron emission tomography (PET), and single-photon emissi...

    $6,000.00
  8. 11 Dec 2015  |  South Asia, Middle East & North Africa  |  Market Research

    Impact of Lifting Nuclear Sanctions on Iran’s Healthcare Market—Now and Later

    The Lifting of Nuclear Sanctions on Iran will open a Plethora of Opportunities in the Medical Tourism and Pharmaceutical Sectors

    Several international sanctions were imposed over Iran over the last decade, restraining its international trade capacity. Yet, Iran is the 17th largest economy in the world; its Gross Domestic Product (GDP) was $415.3 billion in 2014. The nuclear sanctions imposed by the United Nations on Iran resulted in trade bans and restrictions on financial t...

    $1,500.00
  9. 08 Dec 2015  |  Asia Pacific  |  Market Research

    A Product and Pipeline Analysis of the Human Plasma-derived Therapeutics Market

    Launch of Novel Immunoglobulin Products and Increasing Awareness of Therapeutic Options to Drive Double-digit Market Growth

    The Chinese pharmaceutical market is expected to be the third-largest in the world in 2013. This research service analyzes various aspects of the Chinese pharmaceutical market between 2007 and 2016. Rising income, improving healthcare infrastructure, and insurance systems are some factors that drive this market. The study discusses in detail the ma...

    $6,000.00
  10. 11 Nov 2015  |  Asia Pacific  |  Market Research

    Asia-Pacific Point-of-Care Testing Market

    Trends, Challenges, and Best Practices for Stakeholders

    Asia-Pacific (APAC) point-of-care testing (POCT) market was worth $2.80 billion in 2014. In hospitals, POC is used more in emergency rooms (ERs), operation theatres (OTs), recovery rooms (RRs), cath labs, and intensive care units (ICU). The rental model in which the cost of the device is borne by the manufacturer while the profit is shared by the h...

    $4,950.00